Status:
TERMINATED
Genetic Basis of Hemangiomas
Lead Sponsor:
Medical College of Wisconsin
Collaborating Sponsors:
Children's Hospital and Health System Foundation, Wisconsin
Conditions:
Hemangioma, Vascular Anomalies
Eligibility:
All Genders
Brief Summary
The purpose of this study is to determine if there are genes that are common in children with infantile hemangioma. This information will allow physicians to improve care for patients who have been di...
Detailed Description
WHAT IS INVOLVED IN THE RESEARCH STUDY? * Buccal smear (cheek cells) or small blood sample (4 mL or 1 teaspoon) from child being seen in the Dermatology clinic having infantile hemangioma or vascular...
Eligibility Criteria
Inclusion
- Study Population
- No limit to age
- Diagnosis of infantile hemangioma and/or vascular anomaly
- Unaffected twin sibling
- Each patient's authorized legal guardian must understand the nature of the study and must provide written informed consent. Each patient must also give assent to study participation.
- Study Population
Exclusion
- Diagnosis other than infantile hemangioma or vascular anomaly
- If the lesion has resolved and cannot be confirmed as a hemangioma by clinical exam
- If the biologic parents are unwilling or unable to submit DNA samples the child will be excluded from the DNA study. Therefore, if DNA samples cannot be or are not obtained from both biologic parents, the child and family will be excluded from the study.
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00466375
Start Date
April 1 2007
End Date
May 1 2016
Last Update
August 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Wisconsin
Milwaukee, Wisconsin, United States, 53226